Key Competitors - Cardiac Pacing Leads Industry

Jun, 2023 - by CMI

Key Competitors  - Cardiac Pacing Leads Industry

 

A heart pacing lead is a small catheter with two electrodes on it. Through a vein in the hip or neck, it is given to the right ventricle of the heart. In order to depolarize the heart's cells, the leads send electrical impulses to the heart. The two parts of a lead are the electrical leads and the electrode wire. The main thing driving the global market for cardiac pacing leads is the rising number of people with heart problems. People's changing lifestyles, growing fat and sugar intake, risky work practices, and the culture of desk-based work drive the market on a global scale. The world market is also being driven by the fact that people are living longer and are more likely to get heart diseases as they get older. When regulatory bodies give the go-ahead for devices used to set pacing systems, the market grows. The company makes and sells new medical devices to meet doctors' and patients' needs. The global Cardiac Pacing Leads market is being held back by a lack of skilled workers and a lack of general knowledge about heart disease.

Major Players in the Cardiac Pacing Leads Industry:

1. Medtronic

Medtronic is an American medical device company, was founded in 1949 and headquartered in Minnesota, United States. It operates in more than 150 countries. In May 2023, Medtronic set new pace, which means that the company's new leadless pacemakers will have 40% more battery life, which means that most patients will only need one device for life.

2. B Braun Melsungen AG

B Braun Melsungen AG was founded in 1839 and headquartered in Melsungen, Germany. It operates in more than 60 countries. In 2020, B. Braun SE introduced the Aesculap Power Line System, a new surgical power tool system for orthopedic procedures that includes a variety of drills, saws, and reamers. The system's ergonomic design and sophisticated motor technology allow for precise and effective surgical performance.

3.  Biotronik

Biotronik is a limited partnership multinational cardiovascular

 biomedical research and technology company, was founded in 1963 and headquartered in Berlin, Germany. It operates in over 100 countries. BIOTRONIK got CE approval in May 2023 for the world's first pacemaker and CRT-P family that can pace the left bundle branch.

4.  Sorin Group

Sorin Group was a company that made medical products. It was founded in 1956 and based in Italy, but it had major businesses in France, the United States, and Japan. On February 26, 2015, Sorin Group stated that it will join with Cyberonics, another company that makes medical devices, to form a new company called LivaNova. This company will be based in the UK. It operated in more than 100 countries. In March 2023, LivaNova PLC claimed that its EssenzTM Heart-Lung Machine (HLM) has been given 510(k) clearance by the U.S. Food and Drug Administration (FDA). With FDA approval, LivaNova starts to sell Essenz in the United States.

5. Vitatron

Vitatron is a European based international pacemaker company, was founded in 1956 and headquartered in Netherlands. It operates in 120 countries globally.

6.  Biosensors

Biosensors is a medical device company that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care, Its foundation is not specifically known and is headquartered in Singapore. It operates worldwide.

7. Greatbatch Medical

Greatbatch Medical is a developer and manufacturer of components for implantable medical devices (IMDs) and Electrochem batteries, was founded in 1998 and headquartered in United States. It operates in locations of China, Brazil, Mexico, and the Netherlands, as well as the United States.

8.  Edwards Lifesciences

Edwards Lifesciences is an American medical technology company headquartered in IrvineCalifornia, specializing in artificial heart valves and hemodynamic monitoring, was founded in 1958 and headquartered in California, U.S. It operates in nearly 100 countries around the world. In May 2023, Edwards Lifesciences' RESILIA tissue reduced structural valve degradation (SVD) in bioprosthetic aortic valves in the COMMENCE aortic study. At the American Association for Thoracic Surgery's 103rd annual meeting, Edwards' bioprosthetic surgical aortic valve with RESILIA tissue had the longest clinical follow-up, 7.7 years.

9.  BioTrace Medical

BioTrace Medical is dedicated to reinventing temporary pacing to improve patient outcomes and reduce hospitals costs, was founded in 2013 and headquartered in California, United States. It operates in. In April 2021, BioTrace Medical, Inc. said that the company's Tempo® Temporary Pacing Lead was shown in a patient case series at the Society of Cardiovascular Anesthesiologists' 43rd Annual Meeting and Workshops, which took place online in the last week of April.

Definition: A cardiac pacing lead is a small catheter with two electrodes. It is placed in the right ventricle of the heart through the vein in the groin or neck.

 

LogoCredibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.